Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease

Drug Repurposing at the Interface of Melanoma Immunotherapy and Autoimmune Disease

Cancer cells have a remarkable ability to evade recognition and destruction by the immune system. At the same time, cancer has been associated with chronic inflammation, while certain autoimmune diseases predispose to the development of neoplasia. Although cancer immunotherapy has revolutionized ant...

Full description

Bibliographic Details
Main Authors: Alf Spitschak, Shailendra Gupta, Krishna P. Singh, Stella Logotheti, Brigitte M. Pützer
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Pharmaceutics
Subjects:
melanoma
metastasis
autoimmune disease
cancer immunotherapy
tumor immune microenvironment drug repurposing
irAE
Online Access:https://www.mdpi.com/1999-4923/15/1/83

Internet

https://www.mdpi.com/1999-4923/15/1/83

Similar Items